Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Full September 2004 Issue in PDF

  • News from the End of Life

    Ten health care organizations were honored at the American Hospital Association and Health Forums annual Leadership Summit in San Diego on July 26 for their innovative palliative and end-of-life care programs.
  • Tracer methodology focuses on care, not paper

    Mid-cycle self-assessments, tracer methodology, and less emphasis on examination of policy books are all signs that the new survey process implemented by the Joint Commission is truly different from the survey process of the past.
  • Full September issue in PDF

  • News Brief

    Several leading medical and science journals fail to enforce their own policies for disclosing financial conflicts of interest among contributing authors, according to a study released July 12 by the nonprofit Center for Science in the Public Interest (CSPI).
  • Adolescent research needs extra attention

    The very idea of deciding when to waive parental permission or allow investigators to inquire into a teenagers sexual history and drug use may make some IRBs a little nervous. But experts in socio-behavioral research involving adolescents say such situations are common and typically involve less than normal risk.
  • Students learn to work with deaf subjects

    Efforts to improve clinical trial participation among medically underserved populations often overlook one group in particular, say some cancer researchers in California.
  • Committee review, public review part of gene therapy oversight process

    Genetic therapies are rapidly moving from the laboratory into the clinical setting, with more investigators testing experimental gene delivery systems and therapies designed to fundamentally alter our bodies to prevent or treat disease.
  • Pharmacology Watch: The Importance of Publishing Negative Clinical Studies

    Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published. The American Medical Association has recently tackled this issue and has asked the department of Health and Human Services to establish a public registry of all clinical trials in United States.
  • Tool helps pediatric flu immunization programs

    The National Foundation for Infectious Diseases has developed a free on-line resource designed to help health care providers conduct influenza immunization programs for children.